BTK and glioma: The analysis of BTK expression in the whole group of low grade (II WHO) and high grade (III-IV WHO) gliomas demonstrated that p65BTK (BTK+) is significantly more expressed in low grade (II WHO) gliomas (p ≤ 0.05).